𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic Viral Hepatitis and Hepatocellular Carcinoma

✍ Scribed by Yagil Barazani; Jonathan R. Hiatt; Myron J. Tong; Ronald W. Busuttil


Publisher
Springer
Year
2007
Tongue
English
Weight
171 KB
Volume
31
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Expression of transforming growth factor
✍ Young-Hwa Chung; Jeong A. Kim; Byung-Cheol Song; Geun Chan Lee; Moon Soo Koh; Yu πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

The authors thank Dr. Adrian M. Di Bisceglie for helpful suggestions and discussions and also for providing the plasmid-containing, full-length HBV-DNA.

Core promoter mutations (A1762T and G176
✍ Zhong-Liao Fang; Jinye Yang; Xianmin Ge; Hui Zhuang; Jian Gong; Rongcheng Li; Ro πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 148 KB

Hepatitis B viruses (HBV) with core promoter mutations (A(1762)T, G(1764)A) were found in a previous study to be highly prevalent in patients from Guangxi, China with hepatocellular carcinoma (HCC). The aim of this study was to determine whether the mutations are prevalent in areas of Guangxi with h

The toll-like receptor 2 (TLR2) -196 to
✍ Hans-Dieter Nischalke; Martin Coenen; Cordula Berger; Katharina Aldenhoff; Tobia πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 306 KB

## Abstract Chronic hepatitis C virus (HCV) infection is a major risk factor for hepatocellular carcinoma (HCC). HCV proteins core and NS3 can bind to toll‐like receptor 2 (TLR2) and trigger inflammatory responses. Polymorphisms in the __TLR2__ gene predispose to various forms of malignancy but hav